Partner Spotlight | FOMAT Medical Research

Chapel Hill, NC (September 3, 2021) – Devana Solutions, LLC is pleased to announce their newest client-partnership with FOMAT Medical Research, an Integrated Research Organization and partner of the esteemed hyperCORE International, focused on drug, device, and vaccine development. With over ten years of multi-therapeutic clinical trial experience in Phases I-IV, FOMAT relies on a highly experienced clinical research team with the professional expertise needed to assist Sponsors and CROs in reaching their project goals quickly and effectively. To gain further support, FOMAT made the wise decision to implement Devana Solutions’ innovative IGNITE platform.

FOMAT’s mission is to diversify clinical trials throughout the United States & Latin America while innovating healthcare for underrepresented populations. Collaborations with health and urgent care centers, local churches, consulates, community events & centers- in addition to their internal EMR- provides access to over 100,000 patients. It ensures that Good Clinical Practice standards and ethics are upheld and understand that high-quality data is critical to the scientific community to offer improved treatments. Since implementing the Devana IGNITE platform, FOMAT is now armed with the data necessary to push its mission forward.

FOMAT ensures speedy yet compliant project execution for its Sponsor and CRO partners, with a goal of 48 hours to complete feasibility, site selection, and respond to contract, budget, and regulatory. By utilizing the intuitive Devana IGNITE platform, FOMAT can set internal performance goals and easily track its turnaround time metrics for all clinical trial stages. One such metric that FOMAT boasts is a 6-day turnaround time from award to First Patient In (FPI). Quite an accomplishment! These metrics are beneficial for FOMAT to gauge its internal performance and increase its predictability and reliability for its Sponsor and CRO partners.

“Very few of the leading independent research site organizations have not embraced the Devana Solutions platform for clinical trial process and performance transparency. Recently, that list got even shorter with FOMAT Medical Research becoming a Devana partner-client, joining the rest of the hyperCORE International leading site organizations to embrace the Devana Solutions’ innovative analytics and workflow automation platform,” said Devana Solutions, CEO, Barry Lake.

Devana Solutions is proud to partner with the very driven integrated research organization, FOMAT Medical Research, to help increase clinical trial efficiency and ultimately get treatments to patients faster.

ABOUT FOMAT MEDICAL RESEARCH:

FOMAT Medical Research, headquartered in Oxnard, California, is an Integrated Research Organization (IRO), a subset of a Site Management Organization (SMO), focused on innovating healthcare with our high-quality services. With over 10 years of experience in participating in Phase 1 through Phase 4 clinical trials in a wide variety of therapeutic areas, we rely on a highly experienced clinical research team with the professional expertise necessary to assist Sponsors and Contract Research Organizations (CRO) with reaching their project goals quickly and effectively.

Our sites are pre-qualified to ensure their performance will exceed expectations as quickly and effectively as possible. As soon as they enter our network, our sites abide by internationally recognized Good Clinical Practices (GCP) to ensure clinical trials are conducted ethically and effectively. At FOMAT Medical Research, we facilitate every stage of the clinical trial process and provide high-quality services and solutions for sponsors, CROs, and sites. To learn more, visit https://fomatmedical.com/.

ABOUT hyperCORE INTERNATIONAL:

FOMAT Medical Research is one of the founding partners of hyperCORE International’s alliance.

Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. To learn more, visit https://hypercoreinternational.com/.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Partner Spotlight | Icon Group

Devana Solutions, LLC is pleased to announce their newest client-partnership with the Icon Group, Australia’s.

About Devana Solutions: Devana Solutions is a SaaS provider driven by a core belief that performance data transparency through technology is critical to the selection of top-performing research sites to align with pharmaceutical sponsors and CROs to reduce drug development costs and cure disease

Partner Spotlight | SIGAL SMS

Chapel Hill, NC (June 23, 2021) – Devana Solutions, LLC is pleased to announce their newest client partnership with SIGAL Site Management and Support (SIGAL SMS). Founded in 2014, SIGAL SMS began a mission to support traditional private practices in their clinical research execution strategies throughout Germany. Today, the SIGAL SMS network connects over 25 sites across Germany, with an average experience of 55 multi-therapeutic studies and 21 years per site.

Realizing the challenges investigators and study teams face, SIGAL SMS offers extensive knowledge to help sites execute studies at the highest level. They offer complete project management support from study start-up to close-out, acting as a liaison between sites, sponsors and CROs. With their modernized approach, SIGAL SMS provides sponsors and CROs the confidence that studies are conducted in a quality and timely manner.

With a goal to standardize their modern approach in clinical trial conduct, SIGAL SMS needed a platform to help fill the technological gaps in their site and study oversight. Now, by leveraging the Devana IGNITE platform, SIGAL SMS has the ability to automate and centrally manage the processes at each site location to ensure that their studies are successful. With a high-level view into their organizational performance via IGNITE’s robust analytics dashboards, SIGAL SMS can assist sponsors and CROs with accurate site selection. From a single source, sponsors and CROs can obtain a group of professionally set up and qualified sites, with proof of their extensive experience in conducting studies and a high patient potential.

“The clinical trials industry has always been globally focused on advancing therapies to improve the human condition. The recent addition of SIGAL SMS, Germany’s leading research site management organization, onto the Devana Solutions’ platform is a testament to the global reach of the industry and our data analytics and workflow automation technology,” said Barry Lake, CEO & Co-Founder, Devana Solutions, LLC.

SIGAL SMS continues their mission to expand its investigative footprint throughout Germany and set a standard in clinical research at an international level. Devana Solutions is proud to support the SIGAL SMS team and their sites to efficiently carry out studies and advance medicine globally.

ABOUT SIGAL SMS:

SIGAL SMS (SIGAL Site Management & Support) is a Site Management Organization (SMO), which specializes in supporting the development, establishment and optimization of established physicians and outpatient practices nationwide in Germany, on their way to become a professional study site.
With their extensive experience in the field of clinical drug research, they know about the problems and difficulties faced by investigators and study teams as well as contractors – sponsors and CROs – every day in clinical trials. Based on this, they developed a concept and founded SIGAL SMS in 2014 to master these challenges as a reliable and competent partner. To learn more visit https://www.sigal-sms.de/en/.

ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.